NS
NBIX icon

NBC Securities’s Neurocrine Biosciences NBIX Stock Holding History

NBC Securities’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37K Sell
20
-3
-13% -$445 ﹤0.01% 2154
2026
Q1 		$3.03K Hold
23
– – ﹤0.01% 2239
2025
Q4 		$3.26K Sell
23
-1
-4% -$145 ﹤0.01% 2316
2025
Q3 		$3.37K Buy
24
+2
+9% +$271 ﹤0.01% 2303
2025
Q2 		$2K Buy
22
+2
+10% +$229 ﹤0.01% 2299
2025
Q1 		$2K Buy
+20
New +$2.53K ﹤0.01% 2036
2024
Q4 		– Sell
-20
Closed -$2K – 1784
2024
Q3 		$2K Hold
20
– – ﹤0.01% 2031
2024
Q2 		$2K Hold
20
– – ﹤0.01% 1993
2024
Q1 		$2K Hold
20
– – ﹤0.01% 2001
2023
Q4 		$2K Hold
20
– – ﹤0.01% 2021
2023
Q3 		$2K Buy
+20
New +$2.11K ﹤0.01% 2016

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NBC Securities's NBIX Position: Q2 2026 in Review

NBC Securities reduced its Neurocrine Biosciences (NBIX) stake by 13% in Q2 2026, selling an estimated $445 and leaving 20 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

NBC Securities first reported a position in NBIX in Q3 2023 and has held it in 11 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • NBC Securities held 20 shares of Neurocrine Biosciences worth $3.37K as of Q2 2026.
  • NBC Securities sold 3 Neurocrine Biosciences shares in Q2 2026, an estimated $445.
  • Neurocrine Biosciences made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2154 holding.
  • NBC Securities first reported a position in Neurocrine Biosciences in Q3 2023 and has held it in 11 quarters since.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.